Martyn Cobourne

Mr Cobourne undertook specialty training in orthodontics at King’s College Hospital, obtaining his Membership in Orthodontics in 1997. He was appointed as a Senior Lecturer and Honorary Consultant in Orthodontics at King’s College London Dental Institute in 2004 and promoted to Professor of Orthodontics in 2011. He is the author of two successful orthodontic textbooks and is currently Director of Research at the British Orthodontic Society and Editor-in-Chief of the Journal of Orthodontics.

Genomics Radiotherapy and Dysphagia Study

Title  Can genomics predict dysphagia after head and neck radiotherapy?
Acronym GRAD
Study Type Retrospective Case-Control Study
Status Closed to recruitment; in follow-up
Funding  The British Association of Oral and Maxillofacial Surgeons, The John Anderson Cancer Research Trust, Saving Faces – The Facial Surgery Research Foundation
Ethics NRES Committee South East Coast – Surrey, Reference: 14/LO/0429

Continue reading

NFORC Official Public Launch – 26 November 2014

Surgeons and researchers from around the country and beyond gathered on Wednesday, 26th of November for the offical launch of the National Facial, Oral and Oculoplastic Research Centre (NFORC) in the Purcell room on London’s Southbank.

World-famous actor and Saving Faces patron, Alan Rickman , officially opened the Centre, along with NHS Deputy Director, Mike Bewick. The event was presided over by award-winning journalist, Jon Snow.

Continue reading

Professor Walter Gilbert

Professor Gilbert is an eminent molecular Biologist and Nobel Laureate.  He earned a B.A. in Chemistry and Physics from Harvard College, an M.A. in Physics from Harvard University, and a Doctor of Philosophy in Mathematics from Cambridge University.  He has several honorary doctorates.  At Harvard, he has been a Professor of Physics, of Biophysics, of Biochemistry, and of Biology, and also the American Cancer Society Professor of Molecular Biology.  He is currently the Chair of the Harvard Society of Fellows.  Professor Gilbert was a founder and the first CEO of Biogen.  He is a founder and Director of Myriad Genetics and also is a Venture Capitalist.

Osteoradionecrosis Study

Title Can the prophylactic use of a combination of pentoxifylline and vitamin E reduce the incidence and severity of radiotherapy induced complications in head and neck cancer patients – a feasibility study
Study Type Prospective Randomised Controlled Trial
Status  In development
Funding  Saving Faces – The Facial Surgery Research Foundation

Continue reading